Justifying the number of animals for each experiment

Nuclear Medicine and Biology

Volumn 34, Issue 3, 2007, Pages 229-232

  Eckelman, William C ^a   Kilbourn, Michael R ^b   Joyal, John L ^c   Labiris, Renée ^d   Valliant, John F ^d  

^a Molecular Tracer LLC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c A Subsidiary of Lantheus Holdings   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOLIGAND; TRACER;

AUTORADIOGRAPHY; BIOCHEMISTRY; BLOOD FLOW; CONCENTRATION (PARAMETERS); DRUG DISTRIBUTION; EDITORIAL; EXPERIMENTAL STUDY; HUMAN; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOLECULAR IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RODENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE;

ANIMALS; DATA INTERPRETATION, STATISTICAL; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; ETHICS, RESEARCH; INTERNATIONALITY; RADIOPHARMACEUTICALS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 33947423989     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.01.005     Document Type: Editorial

References (12)

1. 18F]FP-TZTP binding by loading doses of muscarinic agonists P-TZTP or FP-TZTP in vivo is not due to agonist-induced reduction in cerebral blood flow. Synapse 50 2 (2003) 151-163
2. Eckelman W.C. The use of PET and knockout mice in the drug discovery process. Drug Discov Today 8 9 (2003) 404-410
3. Zambrowicz B.P., and Sands A.T. Knockouts model the 100 best-selling drugs - will they model the next 100?. Nat Rev Drug Discov 2 (2003) 38-51
4. Zambrowicz B.P., Turner G.A., and Sands A.T. Predicting drug efficacy: knockouts model pipeline drugs of the pharmaceutical industry. Curr Opin Pharmacol 3 (2003) 1-8
5. Eckelman W.C. Sensitivity of new radiopharmaceuticals. Nucl Med Biol 25 3 (1998) 169-173
6. Vera D.R., Krohn K.A., Scheibe P.O., and Stadalnik R.C. Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system. IEEE Trans Biomed Eng 32 5 (1985) 312-322
7. Chatterjee-Kishore M., and Miller C.P. Exploring the sounds of silence: RNAi-mediated gene silencing for target identification and validation. Drug Discov Today 10 22 (2005) 1559-1565
8. GraphPad InStat version 3.0a for Macintosh, GraphPad Software, San U. Diego, S.A. California, www.graphpad.com.
9. Hussey H., et al. Statistical power analysis of in vivo studies in rat brain using PET radiotracers. In: Carson R.E., Daube-Witherspoon M.E., and Herscovitch P. (Eds). Quantitative functional brain imaging with positron emission tomography (1998), Academic Press 273-277
10. Tokugawa J., Ravasi L., Nakayama T., Lang L., Schmidt K.C., Seidel J., et al. Distribution of the 5-HT(1A) receptor antagonist [(18)F]FPWAY in blood and brain of the rat with and without isoflurane anesthesia. Eur J Nucl Med Mol Imaging 34 (2007) 259-266
11. 11C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type mice. Bioorg Med Chem 13 8 (2005) 2993-3001
12. 11C]NMPYB) to endogenous acetylcholine: PET imaging vs. tissue sampling methods. Nucl Med Biol 31 4 (2004) 393-397